# Hyperfine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hyperfine

- Industry: Healthcare
- Headquarters: US
- Website: http://www.hyperfine.io
- Total disclosed funding: $90M
- Latest round: Series D (Feb 10, 2021)
- Investors on record: 7

## About

Founded in 2014 and based in Connecticut, US, Hyperfine, Inc., f.k.a. Hyperfine Research Inc., operates as a developer of MR imaging. The company was founded by Dr. Jonathan Rothberg and in the year 2020, the company received awards as a Best New Radiology Vendor of 2020, American College of Emergency Physicians (ACEP) 2020, Best Practices Product Innovation Award, and most recently 2021 Innovation Awards Honoree. In February 2021, Hyperfine Research, Inc. received USD 90 million in series B funding GV, Nextrans (KClavis-Nextrans), Axiom Associates, Huami, Colle Capital, LSS, and Altium Capital.

The company offers portable MR imaging designed to make MR imaging accessible to every patient particularly when time is in critical condition. MRI uses a magnetic field, radio waves, and tablet to produce pictures of the internal body.

The company revenue generated by developing MRI system enables to help patients with bad conditions in the brain.

Hyperfine, Inc. plans to expand its portable MR imaging platform and immediately launched it in multiple countries.

## Funding rounds

- Series D, Feb 10, 2021, $90M — GV, Altium Capital, Colle Capital, Huami Corporation, Nextrans, LSS Private Equity, Axiom Associates

## Investors

- GV (https://capitalatlas.ai/funds/gv) — Series D
- Altium Capital — Series D
- Colle Capital (https://capitalatlas.ai/funds/colle-capital) — Series D
- Huami Corporation — Series D
- Nextrans (https://capitalatlas.ai/funds/nextrans) — Series D
- LSS Private Equity (https://capitalatlas.ai/funds/lss-private-equity) — Series D
- Axiom Associates — Series D